<p>预计 <strong>唐纳德·特朗普</strong> 将签署一项行政命令，将大麻重新分类为 较低的联邦药物 分类。</p>
<p>特朗普本周早些时候公开表示，该问题正在积极考虑中，并告诉记者重新分类正在 “非常认真” 地权衡。将大麻从《受控物质法》第一类转移到第三类。</p>
<p>毒品执法局将第一类药物定义为没有被接受的医疗用途且具有高滥用潜力，而第三类物质被认为具有中等到低的身体和心理依赖风险。</p>
<p><strong>另请阅读: 特朗普考虑大麻变更：‘很多人想看到它’</strong></p>
<h2>关注股票</h2>
<ul>
<li><strong>Canopy Growth Corporation</strong> (NASDAQ: CGC)</li>
<li><strong>Tilray Brands Inc</strong>. (NASDAQ: TLRY)</li>
<li><strong>Akanda Corp</strong> (NASDAQ: AKAN)</li>
<li><strong>Aurora Cannabis Inc</strong> (NASDAQ: ACB)</li>
<li><strong>Cronos Group Inc</strong> (NASDAQ: CRON)</li>
<li><strong>Flora Growth Corp</strong> (NASDAQ: FLGC)</li>
<li><strong>GrowGeneration Corp</strong> (NASDAQ: GRWG)</li>
<li><strong>IM Cannabis Corp</strong> (NASDAQ: IMCC)</li>
<li><strong>Organigram Global Inc</strong> (NASDAQ: OGI)</li>
<li><strong>SNDL Inc</strong> (NASDAQ: SNDL)</li>
<li><strong>urban-gro, Inc.</strong> (NASDAQ: UGRO)</li>
<li><strong>cbdMD, Inc.</strong> (NYSE: YCBD)</li>
</ul>
<h2>大麻：从竞选话题到现在</h2>
<p>特朗普在椭圆形办公室发言时 告诉 CNN，重新分类可能会解锁目前因联邦法律而受限的科学进展。他指出，许多研究人员因大麻的第一类地位而面临障碍，并补充说，改变可能为更广泛的医学研究打开大门。</p>
<p>这一潜在的行政行动是在特朗普 2024 年总统竞选期间的评论之后提出的。</p>
<p>“我们还必须实施智能监管，同时为成年人提供安全、经过测试的产品的获取，” 特朗普在 2024 年 9 月在 TruthSocial 上 发布 说。“作为总统，我们将继续专注于研究，以解锁大麻作为第三类药物的医疗用途，并与国会合作通过常识法律，包括为州授权公司提供安全银行服务，并支持各州通过大麻法律，例如佛罗里达州，这对他们的公民非常有效。”</p>
<p>预计该命令不会在联邦层面合法化大麻。相反，重新分类可能主要影响税收、研究批准、成年人对受监管产品的获取以及各州在追求自身合法化框架方面的灵活性。</p>
<p><strong>下一步阅读：</strong></p>
<ul>
<li><strong>维韦克·拉马斯瓦米支持的比特币国库股票在首席执行官购买下跌后反弹</strong></li>
</ul>
<p><em>图片来源：Shutterstock</em></p>

TLRY

<p>特朗普总统预计将签署一项行政命令，将大麻从第一类药物重新分类为第三类药物，这将放宽联邦限制，但仍未实现合法化。这一举措可能会促进科学研究，并为各州的合法化框架提供更多灵活性。值得关注的股票包括 Canopy Growth、Tilray 和 Aurora Cannabis。特朗普强调对州授权公司实施智能监管和安全银行业务</p>

<p>President <strong>Donald Trump</strong> is expected to sign an executive order that would reschedule cannabis to a lower federal drug classification.</p>
<div class="lb-trans"><p>预计 <strong>唐纳德·特朗普</strong> 将签署一项行政命令，将大麻重新分类为 较低的联邦药物 分类。</p>
</div><p>Trump publicly indicated earlier this week that the issue was under active consideration, telling reporters that reclassification was being weighed &#34;very strongly.&#34; Moving marijuana from Schedule I to Schedule III under the Controlled Substances Act.</p>
<div class="lb-trans"><p>特朗普本周早些时候公开表示，该问题正在积极考虑中，并告诉记者重新分类正在 “非常认真” 地权衡。将大麻从《受控物质法》第一类转移到第三类。</p>
</div><p>The Drug Enforcement Administration defines Schedule I drugs as having no accepted medical use and a high potential for abuse, while Schedule III substances are considered to have a moderate to low risk of physical and psychological dependence.</p>
<div class="lb-trans"><p>毒品执法局将第一类药物定义为没有被接受的医疗用途且具有高滥用潜力，而第三类物质被认为具有中等到低的身体和心理依赖风险。</p>
</div><p><strong>Also Read: Trump Weighs Marijuana Changes: ‘A Lot Of People Want To See It’</strong></p>
<div class="lb-trans"><p><strong>另请阅读: 特朗普考虑大麻变更：‘很多人想看到它’</strong></p>
</div><h2>Stock To Watch</h2>
<div class="lb-trans"><h2>关注股票</h2>
</div><ul>
<li><strong>Canopy Growth Corporation</strong> (NASDAQ: CGC)</li>
<li><strong>Tilray Brands Inc</strong>. (NASDAQ: TLRY)</li>
<li><strong>Akanda Corp</strong> (NASDAQ: AKAN)</li>
<li><strong>Aurora Cannabis Inc</strong> (NASDAQ: ACB)</li>
<li><strong>Cronos Group Inc</strong> (NASDAQ: CRON)</li>
<li><strong>Flora Growth Corp</strong> (NASDAQ: FLGC)</li>
<li><strong>GrowGeneration Corp</strong> (NASDAQ: GRWG)</li>
<li><strong>IM Cannabis Corp</strong> (NASDAQ: IMCC)</li>
<li><strong>Organigram Global Inc</strong> (NASDAQ: OGI)</li>
<li><strong>SNDL Inc</strong> (NASDAQ: SNDL)</li>
<li><strong>urban-gro, Inc.</strong> (NASDAQ: UGRO)</li>
<li><strong>cbdMD, Inc.</strong> (NYSE: YCBD)</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Canopy Growth Corporation</strong> (NASDAQ: CGC)</li>
<li><strong>Tilray Brands Inc</strong>. (NASDAQ: TLRY)</li>
<li><strong>Akanda Corp</strong> (NASDAQ: AKAN)</li>
<li><strong>Aurora Cannabis Inc</strong> (NASDAQ: ACB)</li>
<li><strong>Cronos Group Inc</strong> (NASDAQ: CRON)</li>
<li><strong>Flora Growth Corp</strong> (NASDAQ: FLGC)</li>
<li><strong>GrowGeneration Corp</strong> (NASDAQ: GRWG)</li>
<li><strong>IM Cannabis Corp</strong> (NASDAQ: IMCC)</li>
<li><strong>Organigram Global Inc</strong> (NASDAQ: OGI)</li>
<li><strong>SNDL Inc</strong> (NASDAQ: SNDL)</li>
<li><strong>urban-gro, Inc.</strong> (NASDAQ: UGRO)</li>
<li><strong>cbdMD, Inc.</strong> (NYSE: YCBD)</li>
</ul>
</div><h2>Cannabis: From Campaign Talking Point To Now</h2>
<div class="lb-trans"><h2>大麻：从竞选话题到现在</h2>
</div><p>Speaking from the Oval Office, Trump told CNN that the reclassification could unlock scientific progress that is currently limited under federal law. He noted that many researchers face barriers studying marijuana because of its Schedule I status, adding that a change could open the door to broader medical research.</p>
<div class="lb-trans"><p>特朗普在椭圆形办公室发言时 告诉 CNN，重新分类可能会解锁目前因联邦法律而受限的科学进展。他指出，许多研究人员因大麻的第一类地位而面临障碍，并补充说，改变可能为更广泛的医学研究打开大门。</p>
</div><p>The potential executive action follows Trump’s comments during the 2024 presidential campaign.</p>
<div class="lb-trans"><p>这一潜在的行政行动是在特朗普 2024 年总统竞选期间的评论之后提出的。</p>
</div><p>“We must also implement smart regulations, while providing access for adults, to safe, tested product,” Trump posted on TruthSocial in September 2024. “As President, we will continue to focus on research to unlock the medical uses of marijuana to a Schedule 3 drug, and work with Congress to pass common sense laws, including safe banking for state authorized companies, and supporting states rights to pass marijuana laws, like in Florida, that work so well for their citizens.”</p>
<div class="lb-trans"><p>“我们还必须实施智能监管，同时为成年人提供安全、经过测试的产品的获取，” 特朗普在 2024 年 9 月在 TruthSocial 上 发布 说。“作为总统，我们将继续专注于研究，以解锁大麻作为第三类药物的医疗用途，并与国会合作通过常识法律，包括为州授权公司提供安全银行服务，并支持各州通过大麻法律，例如佛罗里达州，这对他们的公民非常有效。”</p>
</div><p>The anticipated order would not legalize marijuana at the federal level. Instead, rescheduling could primarily affect taxation, research approvals, adult access to regulated products, and state flexibility in pursuing their own legalization frameworks.</p>
<div class="lb-trans"><p>预计该命令不会在联邦层面合法化大麻。相反，重新分类可能主要影响税收、研究批准、成年人对受监管产品的获取以及各州在追求自身合法化框架方面的灵活性。</p>
</div><p><strong>Read Next:</strong></p>
<div class="lb-trans"><p><strong>下一步阅读：</strong></p>
</div><ul>
<li><strong>Vivek Ramaswamy-Backed Bitcoin Treasury Stock Rallies After CEO Buys Dip Following 25% Pullback</strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong>维韦克·拉马斯瓦米支持的比特币国库股票在首席执行官购买下跌后反弹</strong></li>
</ul>
</div><p><em>Image: Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源：Shutterstock</em></p>
</div>

白宫考虑对大麻进行重新分类，但尚未实现合法化：值得关注的股票